Monday, January 5, 2015

What's,Ahead for Business in 2015

1/5/2015 From Drug Prices to Drones, What's Ahead for Business in 2015- WSJ
THE WALL STREET JOURNAL.
Yom Wdlspem;ahle guide
to ttle bot topics i:l:n~piog
tod~'s ~OOJI liliW'ltets.
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers
visit http://www.djreprints.com.
http://www.wsj.com/articles/from-d rug-prices-to-cl rones-whats-ah ead-for-business-in-2015-14204146 79
BUSINESS
From Drug Prices to Drones, What's
Ahead for Business in 2015
Taking a Look at the Economic and Regulatory Factors Shaping Industry
Jan. 4, 2015 6:38 p.m. ET
ANTHONY FREDA
The old way of doing business is out after a year of big change for many companies. And
2015 promises to deliver more tests and opportunities for established industries andfastgrowing
sectors alike. Part one of two on business in the new year.
Manufacturers Walk Economic Tightrope
For U.S. manufacturers trying to sell their goods abroad, the new year might not be any
easier.
An already enormous U.S. trade deficit in manufactured goods grew even larger in 2014.
For the year's first 10 months, the gap swelled to $606 billion from $540 billion a year
earlier, largely due to weak demand in Europe and in Latin America, two of the main
markets for U.S. goods. Meanwhile, the U.S. imported increasing amounts of
merchandise, from flat-screen televisions to steel pipes, from China.
A stronger dollar made U.S. products more expensive overseas and imports cheaper.
http://www.wsj .com/articles/from-drug-prices-to-drones-whats-ahead-for-business-in-2015-1420414679 1/11
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
In 2015, demand for U.S. goods should be slightly stronger from Europe, Japan and
Latin America, predicts Daniel Meckstroth, chief economist at the MAPI Foundation, a
research group. He also expects the U.S. economy to grow at a faster pace than those of
other advanced economies. That growth, and a strong dollar, will pull in imports.
U.S. exports are strong in some areas, including civilian aircraft, such as Boeing Co.
airliners; industrial machinery, especially for semiconductor plants; and turbines and
engines used for such things as natural-gas transmission and electric-power
generation. Weak areas include electrical lighting and steel products.
Imports of products from iron and steel mills in the first 10 months of 2014 surged 41 %
from a year earlier. China and other countries with excess steel capacity flooded the
U.S. market.
Lower gasoline prices are allowing Americans to spend more on other things. To the
extent they buy cars, trucks and food, that will help U.S. manufacturers.
If they buy clothing, electronics, furniture and other household items, most of the
benefit is likely to flow overseas. At the same time, lower petroleum prices are likely to
hurt sales for U.S. makers of oil-exploration equipment.
One good sign: Investment in manufacturing plants is on the rise. Dodge Data &
Analytics estimates that construction started on 65.1 million square feet of
manufacturing space in the first 11 months of 2014, easily outstripping the 52. 9 million
square feet for all of 2013. Much of that construction relates to petrochemical plants
destined to process growing amounts of shale gas.
-James R. Hagerty
IT Empires Prepare to Strike Back
Big information-technology sellers Microsoft Corp., Cisco Systems Inc. and HewlettPackard
Co. were caught flat-footed as new business-technology trends, such as
software sold by subscription and advanced data-analysis tools, started to gain
traction. Now, the behemoths are waking up and trying to claw their way back to
relevance.
In short, the IT Empires strike back.
The tech giants may never regain their lock on corporate technology. But in 2015,
expect them to play offense by embracing young technologies designed to crush them,
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 2/11
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
swapping out longtime corporate leaders, forming unlikely alliances, or ditching
moneymaking businesses to reinvest in areas that show more potential for growth.
'We can either lie down on the tracks or get on the train," said Crawford Del Prete,
chief research officer of technology-strategy firm IDC, summarizing the big vendors'
attitude.
Once-unusual events became commonplace in 2014. International Business Machines
Corp. sold its profitable but low-margin computer-server business and joined hands
with consumer powerhouse Apple Inc. in business-mobile apps.
H-P, Cisco and Dell Inc. agreed to sell generic computing equipment controlled by rival
companies' software, undercutting their own pricey hardware. Microsoft pitched its
cash-cow Office software on the iPad.
The fuddy-duddies are bound to pull out more surprises in 2015.
IDC predicts Microsoft or IBM will team up with Facebook Inc. this year to jointly
develop software services for corporations. Microsoft watchers wonder whether the
company will make a landmark business shift by offering Windows as an annual
subscription for the first time. The biggest IT vendors will continue scooping up
startups to stay in the game, executives expect.
Wild cards for 2015: Will companies such as Cisco and EMC Corp. shake up top
management? Will big hardware makers weigh a merger, as EMC and H-P did for a time
in 2014?
What's clear is the Empires can't sit still.
IDC says the big IT vendors' bread-and-butter businesses are shrinking or stagnant,
and predicts one-third of all corporate IT spending this year will be in emerging areas
like mobile, data analysis, cloud computing and digital intelligence. That is up from
about 10% of IT spending a few years ago.
-Shira Ovide
Drug Prices to Get More Expensive
The $1,000-a-day price of a new hepatitis C pill has put more attention on the rising
cost of drugs.
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 3111
1/5/2015 Fran Drug Prices to Drones, Whafs Ahead for Business in 2015- WSJ
Yet the hefty price tags of new medicines like Sovaldi from Gilead Sciences Inc.,
weren't the only culprit in higher drug costs last year. Price increases on older
drugs played a big part, too-and the costs are expected to keep soaring.
Brand-name drug prices surged 14% in the 12 months through the end of the third
quarter in 2014, adding $32 billion to drug spending, said Elliot Wilbur, a Needham &
Co. analyst. Up 2.5% were the prices of generic drugs, which are supposed to be an
instrument for cutting drug spending.
"If anything, 2015 list prices will grow more quickly than in 2014," said Richard Evans, a
former drug industry pricing official now an analyst at SSR Health LLC.
Drug companies say they are being unfairly criticized on prices. Medicines account for
only a 10th of overall health-care spending in the U.S., and drug treatments save on
larger expenses like liver transplants, said Robert Zirkelbach, a spokesman for the
industry's trade group, the Pharmaceutical Research and Manufacturers of America.
A big reason for the drug-price inflation, analysts say: Health insurers and pharmacybenefit
managers have lacked the wherewithal to stop it.
Their tools tend to be blunt instruments such as raising copays, which drug companies
have been able to counteract by offering subsidies to many patients.
The payers are trying. Express Scripts Holding Co. , the largest manager of drug
benefits in the U.S., moved in late December to restrict access to Gilead's hepatitis C
drugs after negotiating a discount for a rival regimen from AbbVie Inc. Yet such steps
are possible only when there is competition, which often isn't the case. And in some
previous instances, drug companies still found ways to raise prices, Mr. Evans said.
The payers may gain more leverage eventually, at least for generic drugs. Big drug
distributors and pharmacies-such as AmerisourceBergen Corp., Walgreen Co. and
Alliance Boots GmbH-have been linking up to use their combined drug-buying volume
to press for lower prices.
But it will probably be harder to stop doctors and patients from sticking with brandname
drugs whose prices are boosted, especially if patients are doing well on a
medicine.
The trajectory of Sovaldi in 2014 illustrated the generally favorable pricing climate for
drug companies. Doctors and patients flocked to the cure, making it the best-selling
htlpJ/www.wsj.can/articleslfran-drug-prices-\o-drones-whats--lor-business-in-2015-1420414679 4111
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
launch of a new drug with $8.55 billion in sales during the first nine months of 2014.
Prescriptions for a new Gilead hepatitis C pill, Harvoni, suggest a similarly strong
launch into 2015, though the Express Scripts move will limit some sales. Harvoni's
price tag for a typical patient treated for 12 weeks: $94,500.
-Jonathan D. Rockoff
More CEOs Could Be Headed for the Exit
Chief executives in surprising numbers were shown the exit during 2014-and the
revolving door may not stop there.
At least 14 top bosses of U.S. big businesses got pushed aside or left under pressure-six
in December alone.
In the S&P 500 index, 45 companies replaced their CEOs for any reason during the first
nine months of 2014, reports recruiters Spencer Stuart. At that rate, the number of
companies swapping leaders in all of 2014 would have exceeded the 53 that did so in
2013. (Tallies exclude interim CEOs.)
Among those who left in 2014 were CEOs of Bob Evans Farms Inc., Hertz Global
Holdings Inc., Target Corp. , United Technologies Corp. and Symantec Corp.
The powerful forces of bolder shareholder activists and impatient boards mean "more
CEOs will get ousted in 2015," suggests Jeffrey Cohn, a CEO succession expert.
Activists had success sweeping out several corner-office occupants during 2014.
Darden Restaurants Inc. 's Clarence Otis, longtime chairman and CEO of the restaurant
chain, said in July that he would relinquish the top spot by year-end. The
announcement didn't appease unhappy investors. Starboard Value LP, Darden's
second biggest shareholder, led an October takeover of the entire 12-person board.
Days later, the new board appointed an interim chief and gave the chairmanship to
Starboard chief Jeffrey Smith.
Flawed leadership traits influenced the sudden departures of some CEOs. Juniper
Networks Inc. 's Shaygan Kheradpir left after less than a year at the helm. The
November move followed a review of his leadership and how he handled a customer
negotiation, but he and the board didn't see eye to eye on those matters, the company
said.
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 5111
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
"The swiftness of the forced exit is happening more now," says Michael Useem, a
management professor at University of Pennsylvania's Wharton School. He expects
commanders of companies in slow-growing industries, such as energy, may find they
are especially vulnerable in 2015.
-Joann S. Lublin
Rail Operators' Fixes To Be Tested in 2015
Rail congestion that caused headaches for shippers of everything from corn to coal may
start to ease in 2015 as operators spend more to increase capacity.
The entire transportation industry experienced capacity strains in 2014 as the U.S.
economy continued to recover. Rail was one of the hardest hit areas, with unexpectedly
strong demand and bad weather taking their toll on service.
Severe delays for shipments of corn, soybeans and other crops in the upper Midwest
began in early 2014, with bitterly cold temperatures forcing operators to run shorter,
slower trains even as a record harvests produced more grain needing transport. The
snarls returned after another bumper harvest in the autumn. The coal industry also has
complained of significant delays, particularly in the western U.S.
To fix this, railroads includingBNSF Railway Co., owned by Warren Buffett 's Berkshire
Hathaway Inc., are collectively spending about $2 billion a month in capital
investments, says the American Association of Railroads. The companies hired 17,000
workers last year, some 40% higher than initial projections, and several have
announced significant capital spending and hiring plans for this year.
"As locomotives are added, as crews are added, I think you'll see some of the issues get
better as 2015 progresses," said Mark Levin, a rail analyst with BB&T Capital Markets,
who expects significant improvement by midyear.
A mild winter so far has helped. Additionally, as oil and natural gas prices continue to
tumble, both industries may use less rail capacity for carrying those products as well as
for transporting items such as fracking sand.
Lisa Richardson, executive director of the South Dakota Corn Growers Association,
said turnaround times for railcars to the Pacific Northwest, where crops like corn go
for export, have accelerated in recent months.
Still, grain groups say the real test will come during the first few months of 2015, when
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 am
1J5"2015 From Drug Prices tD Draies, What's Ahead for Businass in 2015-WSJ
Railroads, including BNSF Railway, are collectively spending about $2 billion a month in capital investmen1s. BISMARCK
TRIBUNE/ASSOCIATED PRESS
farmers may begin to more aggressively market their corn and soybean crops.
"I think we,re getting through the growing pains/' said Dan Wogsland, executive
director of the North Dakota Grain Growers Association. "But things can tum on a
dime around here."
-Laura Stevens and Jesse Newman
Screws to Tighten on Google in Europe
Google Inc. is under increasing attack across Europe, from taxes and competition law
to Europe's newly established right for individuals to demand removal of information
about themselves from Web searches.
While many of these battles with policy makers and regulators have been simmering
for a while, several likely will come to a boil this year-raising the specter of a
permanently changed relationship between U.S. tech titans and Europe.
Take competition. Google has for years been trying to settle complaints that it abuses
htlp://www.w&j.can/articlesll'rom-d"ug-JJ"ice&-ID-drones-whals-ahead-for-busine6&-in-2015-1420414679 7/11
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
its dominant position in the online-search market. But Germany is now leading a
charge to convince the European Union's new competition czar, Margrethe Vestager,
to quickly take a harder line against the company-backed by the European parliament.
Or privacy. The way Google has applied Europe's "Right to Be Forgotten" is likely to
tumble into court-or courts-this year as data-protection authorities demand that
Google start scrubbing offending personal results world-wide, not just in Europe.
At the same time, European governments are pushing to pass a tough new data-privacy
law this year that could beef up privacy fines to as much as 5% of a company's global
revenue. And the Luxembourg-based European Court of Justice is expected to rule as
early as summer on whether to end the "Safe Harbor'' mechanism that lets many
companies-including Google-send EU personal data to the U.S.
Taxes will be a hotter topic as well. The Organization for Economic Cooperation and
Development will hit its deadline this fall for completing recommendations for how to
make companies like Google pay more corporate taxes. Complicating matters is the
U.K.'s April deadline to implement its controversial new tax aimed at companies that
divert profit to tax havens-dubbed the "Google Tax."
Southern and eastern flanks in Europe are exposed as well. Spanish publishers' battle
to getting Google may continue after Google removed them from part of Google News.
And in Russia, Google is among the companies that will have to contend with a new law
that by September is slated to force local storage of data about Russians.
Google, for its part, insists that it respects European law and that it injects wealth into
the countries where it operates. The company has sent senior executives across the
region to press its case. But it remains unclear how far those arguments will go-or
whether 2015 will become Google's year to remember.
-Sam Schechner
Retailers SeekFootingAfter Many Missteps
After many tough years, the improving economy may offer new hope for the retail
industry-and if not, there is new leadership to try to fix it.
. The U.S. economy grew at its strongest pace in 11 years in the third quarter.
Consumer confidence surged in early December to its highest level since February
2008, early in the last recession. Unemployment has eased and low gasoline prices are
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 8111
1/&'2015 Fran Drug Prices to Dral8S, What's Ahead for Business in 2015- WSJ
providing much needed relief for the country's poorest shoppers.
That may provide some relief for big-box stores Target Corp. and Wal-Mart Stores Inc.,
where shopper visits have declined for eight straight quarters. Other chains including
Sears Holdings Corp., J.C. Penney Co. and Abercrombie & Fitch Co. are all mired in
long slumps as they grapple with changing shopping habits and try to fend off
competition from online retailers like Amazon.com Inc.
Both Wal-Mart and Target notched sales gains in their latest quarter, but at the
expense of profitability as retailers ratcheted up promotions to clock higher revenues.
A new crop of chief executives will be tackling the landscape where a greater share of
shopping is done online. Wal-Mart, Target, Gap Inc., Home Depot Inc., Abercrombie,
American Apparel Inc. and J.C. Penney are among chains with new or soon-to-be new
CE Os.
On the low end, the three largest dollar-store chains remain locked in a merger saga.
Dollar General, the largest chain by number of location and sales, is trying to buy its
close rival, Family Dollar, and scuttle a planned sale to Dollar Tree . A new Family
Dollar shareholder vote is slated for this month.
Retailers will have one thing to be thankful for as they start 2015: Weather. Last year,
the first few months of shopping were hit hard by frigid weather that swept across the
U.S. Forecasters predict that a milder spring could bring another measure of relief.
-Paul Ziobro
Bigger, Better Drones, But Not Drone Rules
Drones made the leap from the battlefields to American backyards last year, raising
concerns about air safety, privacy and regulation.
In 2015, unmanned aircraft in the U.S. will continue to multiply, likely exacerbating the
issues of 2014 while U.S. regulators try to finish rules for the devices.
The Federal Aviation Administration missed its self-imposed deadline of Dec. 22 to
propose rules for small commercial drones in the U.S.-regulations it began working on
more than five years ago. The agency expects to propose the rules by early 2015,
launching a public-comment period that it expects to draw tens of thousands of
comments.
htlp://www.wsj.com/articles/fran-drug-prices-to-drones-whats-ahead-for-business-i n-2015-1420414679 Ql11
1J5"2015 From Drug Prices tD Draies, What's Ahead for Businass in 2015-WSJ
For that reason, 2015 will be
a crucial year for drones in
the U.S. Those excited for
the technology-and those
concerned about it-will be
able to voice their opinions
on how the government
should regulate drones.
Regulators are required to
consider comments, which
often help craft final rules.
Meanwhile, many U.S.
The FAA expects to soon propose rules for small commercial drones. REUTERS entrepreneurs are using the
devices despite an effective
ban on their commercial use by the FAA. Officially, the FAA has approved just 13
commercial drones through a case-by-case approval process the agency is using to ease
pent-up demand.
There are more than 140 pending applications for such exemptions, and the FAA plans
to issue more approvals in 2015, likely turning a few big companies into drone users.
Chevron Corp. wants to use drones to monitor its oil and gas plants, for instance, and
State Farm Insurance Cos. wants to use them to conduct insurance inspections after
natural disasters.
Another company will likely turn into a drone maker in 2015. GoPro Inc., the wearablecamera
maker, is aiming to launch its own line of consumer drones in late 2015, priced
between $500 and $1,000, according to people familiar with the company's plans.
Meanwhile, Amazon.com has said that 2015 would be the year it introduces its delivery
drones-if the FAA establishes rules for the devices by then. But the holdup in
regulations will almost certainly delay thee-retailer's plans.
The Government Accountability Office recently said the FAA won't issue final rules for
commercial drones until late 2016 or early 2017. Delivery drones will likely have to wait
until then.
-JackNicas
htlp://www.w&j.can/articlesll'rom-d"ug-JJ"ice&-ID-drones-whals-ahead-for-busine6&-in-2015-1420414679 1Q/11
1/5/2015 Fran Drug Prices to Drones, Whafs Ahead for Business in 2015- WSJ
Copyright 2014 Dow Jones & Company, Inc. All Rights Reserved
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by
oopyright law. For non-personal use or to artier multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
htlpJ/www.wsj.can/articleslfran-drug-prices-\o-drones-whats--lor-business-in-2015-1420414679 11/11



This email has been checked for viruses by Avast antivirus software.
www.avast.com


Fwd: my top tech picks for 2015




-------- Forwarded Message --------
Subject: my top tech picks for 2015
Date: Sun, 4 Jan 2015 10:21:31 -0800
From: Peter Diamandis <peter@diamandis.com>
Reply-To: peter@diamandis.com
To: Steve <stevescott@techacq.com>


If you thought 2014 was thrilling, here's a look at what I'm most excited about for 2015…

With CES happening next week, Abundance 360 at the end of January, and A360-digital kicking off in March, here are 11 of the most exciting new technologies moving from deceptive to disruptive this year.

  1. Virtual Reality: Expect a lot more action on the virtual and augmented reality front. 2014 saw the $2B acquisition of Oculus Rift by Facebook. In 2015, we'll see action from companies like Phillip Rosedale's High Fidelity (the successor to Second Life), immersive 3D 360-degree cameras from companies like Immersive Media (the company behind Google's Streetview), Jaunt, and Giroptic. Then there are game changers like Magic Leap (in which Google just invested over $500 million) that are developing technology to "generate images indistinguishable from real objects and then being able to place those images seamlessly into the real world." Oculus, the darling of CES for the past few years, will be showing its latest Crescent Bay prototype and hopefully providing a taste of how its headset will interact with Nimble VR's hand- and finger-tracking inputs. Nine new VR experiences will be premiering at the Sundance Film Festival this year, spanning from artistic, powerful journalistic experiences like Project Syria to full "flying" simulations where you get to "feel" what it would be like for a human to fly.
  2. Mass-market robots: 2014 saw the acquisition by Google of eight robotics companies. 2015 is going to see the introduction of consumer-friendly robots in a store near you. Companies like SU's Fellow Robots are creating autonomous "employees" called Oshbots that are roaming the floors of Lowe's and helping you find and order items in their store. We'll also see Softbank's Pepper robot make the leap from Japan to enter U.S. retail stores. Pepper uses an emotion engine and computer vision, to detect smiles, frowns, and surprise, and it uses speech recognition to sense the tone of voice and to detect certain words indicative of strong feelings, like "love" and "hate." The engine then computes a numeric score that quantifies the person's overall emotion as positive or negative to help the store make a sale. At CES, Paris-based start-up Keecker will show off a robot that doubles as a movie projector after raising more than $250,000 for the idea on Kickstarter.

    Fellow Robot autonomous                  employee

    Fellow Robot autonomous employee

  3. Autonomous vehicles: In 2015, we will see incredible developments in autonomous vehicle technology. Beyond Google, many major car brands are working on autonomous solutions. At CES, Volkswagen will bring the number of car brands on display into double figures for the first time this year. Companies like Mercedes say they will show off a new self-driving concept car that allows its passengers to face each other. BMW plans to show how one of its cars can be set to park itself via a smartwatch app. And, Tesla, of course, has already demonstrated "autopilot" on its Model D.
  4. Drones everywhere: 2015 will be a big year for drones. They are getting cheaper, easier to use, more automated, and are now finding more useful and lucrative applications. These "drones" include everything from the $20 toys you can buy at RadioShack to the high-powered $1000+ drones from companies like DJI and the super-simple and powerful Q500 Typhoon. These consumer drones equipped with high quality cameras and autopilot software are military-grade surveillance units now finding application in agriculture, construction and energy applications. Drones get their own section of CES in 2015 with a new "unmanned systems" zone. Wales' Torquing Group could provide one of its highlights with Zano, a Kickstarter-backed quadcopter small enough to fit in your hand but still capable of high-definition video capture.

    Zano, a                  Kickstarter-backed quadcopter

    Zano, a Kickstarter-backed quadcopter

  5. Wireless power: "Remember when we had to use wires to charge our devices? Man, that was so 2014." Companies like uBeam, Ossia and others are developing solutions to charge your phones, laptops, wearables, etc. wirelessly as you go about your business. And this isn't a "charging mat" that requires you to set your phone down… imagine having your phone in your pocket, purse, or backpack, and it will be charging as you walk around the room. Companies are taking different approaches as they develop this technology (uBeam uses ultrasound to transfer energy to piezoelectric receivers, while Ossia has a product called Cota that uses an ISM radio band, similar to Wifi, to transfer energy and data). Look out for a key "interface moment" in 2015 that will take wireless power mainstream.
  6. Data & machine learning: 2014 saw data and algorithm driven companies like Uber and AirBnb skyrocket. There is gold in your data. And data-driven companies are the most successful exponential organizations around. In 2015, data collection and mining that data will become more turn-key. Platforms like Experfy, for example, allow you to find data scientist who will develop algorithms or machine learning solutions for your business/project. Larger companies can explore partnering with IBM's Watson Ecosystem, which is creating a community of everyone from developers to content providers to collaborate and create the next generation of cognitive apps. Companies built around algorithms, like Enlitic (a company that uses machine learning to detect tumors and make medical imaging diagnostics faster and cheaper), will become much more prevalent and common in 2015.
  7. Large-scale genome sequencing and data mining: We are at the knee of the curve of human genome sequencing. In 2015, we will see explosive, exponential growth in genomics and longevity research. As the cost of sequencing a single human genome plummets by orders of magnitude (now around $1,000) and the amount of useful information we glean from mining all that data skyrockets. At Human Longevity Inc (HLI), a company I co-founded, we are aiming to sequence 1 million to 5 million full human genomes, microbiomes, metabalomes, proteomes, MRI scans, and more by 2020. We're proud to have Franz Och, formerly the head of Google Translate, as the head of our machine learning team to mine the massive amount of data so that we can learn the secrets to extending the healthy human lifespan by 30-40 years.
  8. Sensor explosion: In 2015, expect "everything" to be "smart". The combination of sensors and wearables, increased connectivity, new manufacturing methods (like 3D printing), and improved data mining capabilities will create a smart, connected world – where our objects, clothes, appliances, homes, streets, cars, etc., etc. will be constantly communicating with one and other. Soon, there will be trillions of sensors throughout the world. These sensors won't just power smart ovens and sweatshirts -- the same technology will allow companies like Miroculus to create "microRNA detection platform that will constantly diagnose and monitor diseases at the molecular level." Sensors are going to be taking over CES this year. Among the many applications: a shirt that can read your heart-rate by Cityzen Sciences, a device from HealBe that can automatically log how many calories you consume, a garden sprinkler system from Blossom that can decide when to switch on based on weather forecasts, pads for the pantry from SmartQSine that allow you to keep track of how much of your favorite foods are left, a pacifier from Pacifi that sends the baby's temperature to the parent's smartphone, and a new home security system from Myfox with tags you can attach to a door or window that trigger alarms before a break-in is attempted.
  9. Voice-control and "language-independent" interaction: Using our fingers to operate smartphones/technology was "so 2014". In 2015, we will see significant advances in voice-controlled systems and wider mass market adoption. Think the first steps towards a Jarvis-like interface. Siri, Google Now, Cortana, and other voice control systems are continuing to get better and better – so much so that they are being almost seamlessly integrated into our technology, across platforms. Soon, almost all connected devices will have voice-control capabilities. Companies like Wit.ai are creating their own open-source natural language interfaces for the Internet of Things and for developers to incorporate into their apps, hardware, and platforms. Jarvis-like systems like the Ubi and Jibo, plus IBM's Watson and XBOX One Kinect, already allow natural language interactions and question/answer like commands. Then, Google Translate, Skype Translate, and others are creating software that allows real-time translation between languages, further eliminating cultural and geographic barriers – the Star Trek universal translator is just around the corner!
  10. 3D Printing: 3-D printing will continue to grow rapidly in 2015 as the number of applications increase and as printers, scanners, and CAD modeling software become more accessible, cheaper, and easier to use. 2014 saw the first 3D printed object in space, by SU company, Made-in-Space. 3DSystems continues to innovate around the clock and is releasing a plethora of exciting things in 2015, including 3D printed food and customized chocolates. Three years ago there were just two 3D printing firms at CES. This year there promises to be more than 24.
  11. Bitcoin: While 2014 was a rough year for bitcoin (it was ranked the "worst performing currency"), I am optimistic that 2015 will be a better year for the cryptocurrency. Weak currencies and uncertainty in the global economy, emerging smartphone markets in developing countries (billions coming online for the first time), better "interfaces", and more commercial adopters who accept bitcoin as a form of payment will all play a role in a brighter bitcoin future. Finally it's worth noting that Apple Pay will ultimately teach an entire generation how to navigate life without cash… making the transition to bitcoin natural and easy.

Creating a World of Abundance

If you're joining me as a part of my executive Mastermind group A360 this year, you'll be seeing and hearing about these developments firsthand, from their creators.

We'll talk about timelines, projections, applications, and opportunities for each of them in the year and years ahead.

While A360 is full, I've also created a new digital extension of A360 called A360d.

This is a digital mastermind where entrepreneurs (like you), can gain access to the knowledge, resources and tools we discuss at A360 and learn how to develop your own moonshot thinking.

A360D will aim to connect you with other bold and abundance-minded entrepreneurs, and to connect you with me on a monthly basis for discussion around these topics.

I'll be rolling out A360D in early 2015. If you'd like me to send you more info, then submit your name and email here.

Happy New Year!

All the best,
Peter

P.S. Every weekend I send out a "Tech Blog" like this one. If you want to sign up, go to PeterDiamandis.com and sign up for this and my Abundance blogs.

P.P.S. Please forward this to your best clients, colleagues and friends — especially those who could use some encouragement as they pursue big, bold dreams.


If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
PHD Ventures , 800 Corporate Pointe, Culver City CA, 90230






This email has been checked for viruses by Avast antivirus software.
www.avast.com


WSJ What's ahead for business 2015 ocr

WSJ What's ahead for business 2015

Monday, December 29, 2014

Fwd: dissolving national borders




-------- Forwarded Message --------
Subject: dissolving national borders
Date: Sun, 28 Dec 2014 11:11:59 -0800
From: Peter Diamandis <peter@diamandis.com>
Reply-To: peter@diamandis.com
To: Steve <stevescott@techacq.com>


Besides your passport, what really defines your nationality these days?

Is it where you were live? Where you work? The language you speak? The currency you use?

If it is, then we may see the idea of "nationality" quickly dissolve in the decades ahead.

Language, currency and residency are rapidly being disrupted and dematerialized by technology.

Here's how.

Where you live, where you work…

Increasingly, technological developments will allow us to live and work almost anywhere on the planet... (and even beyond).

Soon, you'll be able to live in the Greek Islands and work in Manhattan, London, and Los Angeles.

Telepresence & Virtual Environments

Today I use telepresence robots to telecommute around the globe, attend an XPRIZE meeting in India, or if I'm overseas, pop home for breakfast or dinner with my kids.

The product I personally use comes from Suitable Technology and is called the "Beam." I have about 15 beams across my different companies, and I'll be integrating another 20 beams into my Abundance 360 Summit this January 25-27 so that some of the participants on the waiting list can attend virtually.

Beyond these telepresence technologies, the biggest impact on dematerializing nationality will come from development of fully immersive, high fidelity, virtual worlds. Virtual workplaces you plug into using VR gear to interact with other virtual workers (perhaps even A.I.'s) on a daily basis.

The earliest example of a virtual world where people were "living" and "working" is Phillip Rosedale's Second Life.

You can think of it as a proof of concept, an early prototype of what is coming.

Think of it as pong, compared to today's video games.

Even as rudimentary as Second Life is today, its annual revenues have reached US$567 million, and since its inception, it has transacted over US$3.5 Billion as people build and sell virtual products in this virtual world. Not bad…

But what is coming next will be transformational.

With the creation of new VR technologies (Oculus Rift technology, Samsung Gear) and 360-degree camera technology (Immersive Media, Jaunt), we'll be able to slide on a pair of Goggles and "go" anywhere in the real and virtual world.

Companies will forgo bricks and mortar, and instead allow its work-force, from around the world, to beam into the same environment and work cooperatively. Think about a 'kinder-gentler ' version of the Matrix.

What language you speak…

We are headed toward a world where everyone will have the tools to speak every language, in real time.

Right now, Google Translate does a damn good job. The system built by Franz Och at Google over the last decade can now support translation between 80 language pairs. (Note: Franz is now heading machine learning at Human Longevity Inc, where he is helping to translate between the languages of genetics, phenotype and metabolome.

In 2013, Google stated that Translate served 200 million people, daily.

Another more recent example of simultaneous translation, this time between spoken word is Skype's recently announced "Live Translate."

Skype's embedded artificial intelligence promises to translate your voice into another language in close to real-time while you are video-Skyping someone else on the other side of the planet (right now, it only serves English/Spanish translations).

The bottom line: Star Trek universal translator is here and it's going to be a game-changer.

What currency you use…

Decentralized, unregulated cryptocurrencies (like bitcoin) will make it MUCH easier to trade and transact both across and within borders.

While this year hasn't been so great for bitcoin, the fact is, cryptocurrencies are here to stay and will find more and more useful applications.

Take the recent Russian ruble crisis for example.

In Q4 2014, the ruble had a rapid devaluation due to political instability and the crashing price of oil, ending up at a 14-year low.

So what happened?

Russians have started pouring money into bitcoin.

In mid-December 2014, CNBC reported, "Transaction volumes between the ruble and digital currency bitcoin enjoyed their biggest day of the year. This was close to a 250 percent increase in transactions."

Bitcoin dematerializes the banks, and demonetizes transaction fees. It is global and unregulated. And it is easy to use.

With these characteristics, we will see a shift away from national currencies toward global cryptocurrencies that provide some level of stability and independence from your country's political turmoil, or whether your country's GDP is based on oil exports.

Consequences for the Entrepreneur/CEO

We live in the most exciting time ever.

In my mind, a borderless world will be a more creative, lucrative, healthy, and frankly, exciting one.

Especially for entrepreneurs.

A world where you, as an entrepreneur can now become a 'multinational corporation', accessing 5 billion potential customers.

I have a team that works with me to research and study these meta-trends.

I've decided to create a digital extension of my Executive Mastermind.

This is digital mastermind called Abundance 360 Digital (or A360D) where entrepreneurs (like you), can get monthly on-line access to the knowledge, resources and tools resulting from exponential technologies, crowd-related tools (incentive competitions, crowdfunding, etc.) and moonshot thinking.

A360D will aim to connect you with other bold and abundance-minded entrepreneurs, and to connect you with me on a monthly basis for discussion around these topics.

I'll be rolling out A360D in early 2015. If you'd like me to send you more info then submit your name and email here.

Happy holidays & happy New Year.

Peter

P.S. Every weekend I send out a "Tech Blog" like this one. If you want to sign up, go to PeterDiamandis.com and sign up for this and my Abundance blogs.

P.P.S. Please forward this to your best clients, colleagues and friends — especially those who could use some encouragement as they pursue big, bold dreams.


If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
PHD Ventures , 800 Corporate Pointe, Culver City CA, 90230



Sunday, December 21, 2014

Fwd: know anything you want, anytime, anywhere




-------- Forwarded Message --------
Subject: know anything you want, anytime, anywhere
Date: Sun, 21 Dec 2014 12:47:19 -0800
From: Peter Diamandis <peter@diamandis.com>
Reply-To: peter@diamandis.com
To: Steve <stevescott@techacq.com>


We're heading towards a world of perfect knowledge.

Soon you'll be able to know anything you want, anytime, anywhere, and query that data for answers and insights.

Why is this happening? And what are the implications? These are the questions this blog will explore. It's also one of the meta-trends I'm discussing with my digital mastermind group (Abundance 360 Digital).

An explosion of ubiquitous, omnipresent cameras

The first digital camera built by Kodak in 1976 was a 0.01 Megapixel camera.

It was the size of a toaster and cost thousands of dollars.

Today's digital cameras are 1 billion times better.

In a decade, they will be 1 trillion times better.

Where is ubiquitous imaging/sensing heading?

LiDAR imagery from Google's              autonomous car project

Image Above: LiDAR imagery from Google's autonomous car project

  • Imaging from our streets: Fleets of autonomous cars will image everything in and around our roads, constantly. A single Google Autonomous car using LiDAR (laser imaging radar) generates over 1.3 million points per second (750 Mbits/sec of data) in a "360° view" (see image below).
  • Imaging from space: Today there are three private orbital satellite constellations with two more being planned soon. These near-real time imaging services from space are offering 0.5 meter to 5 meter resolution of any spot on the planet, with video and multi-spectral options.
  • Imaging from our skies: Beyond orbiting satellites, we will soon have armies of drones flying above our streets imaging the ground at centimeter resolution.
  • Imagine from our sidewalks: Whatever Google Glass becomes, we'll see a future where people walk around with always-on, active cameras that image everything on our streets, at millimeter resolution.

NOTE: These are examples just from the realm of ubiquitous imaging sensors. Beyond this, there will be an explosion of audio/vibration, genomics and biometrics sensors, to name just a few.

In the decade ahead, we're heading towards a trillion-sensor world. In 2013, we generated 4 zettabytes (4x1021bytes) of data. Data generation is doubling every two years and accelerating. By 2020 we'll be up to 44 zettabytes (i.e. 44 trillion gigabytes).

Then, with the power of machine learning, data science, increased computational power, and global connectivity we can process, learn from, explore, and leverage that information to ask and answer almost any question.

Questions we will be able to ask, and get answered…

Who caused that accident? While autonomous cars are unlikely to crash (bad news for the insurance industry), accidents caused by human-driven cars on the road will never be mysteries again. Imagery from LIDAR or equivalent sensors will tell you exactly who caused the accident and how.

How's my competitor performing? Orbital satellite imaging can tell you exactly how many cars were in competitor's parking lot last weekend. Which locations attract more shoppers? What is the status of your competitor's supply chain – raw materials in, and finished products out?

Where did that gunshot come from? ShotSpotter, a gunfire detection technology gathers data from a network of acoustic sensors placed throughout a city, filters the data through an algorithm to isolate the sound of gunfire, triangulates the location within about ten feet, then reports it directly to the police. It's more accurate than info from 911 callers.

What is the most popular dress color Friday night in Manhattan? Want to know the fashion trends in your city? You will be able to gather images and mine them to determine the most popular colors and fashions on any street, mall or borough.

What is the prevalence of heart disease or Alzheimer's in my neighborhood? This may sound disgusting, but imagine sampling the sewage coming out of your neighborhood. By analyzing the DNA in biological waste in those pipes, you can tell the prevalence of one disease over another in that community. Do you think that might be of interest to a health or life insurance company?

Who are the happiest people in the U.S.? Researchers from the University of Vermont used Mechanical Turk to rank thousands of words by "happiness" levels. They then wrote an algorithm that analyzed 10 million tweets, used the Mechanical Turk data as a training set, and determined which are the happiest U.S. states (Hawaii) and the saddest (Louisiana). They could even explore semantic trends down to the zip-code.

Show's Happiness by              Geography for U.S. and Chicago, IL

Image Above: Shows Happiness by Geography for U.S. and Chicago, IL

Consequences for the Entrepreneur/CEO – A360 Digital

I think about this stuff a lot.

We live in the most exciting time ever.

As we move towards a world of perfect information, we are going to be disrupting many industries and creating even more entrepreneurial business opportunities.

Which industries are going to change because of this data revolution?

All of them.

If you'd like to join me in these discussions around technologies and meta-trends, I am creating a digital Mastermind group called Abundance 360 Digital.

A360D is developed specifically for entrepreneurs (like you), to provide you with monthly access to the knowledge and tools resulting from exponential technologies, moonshot/abundance thinking and crowd-related tools.

If you'd like me to send you more info on A360D, submit your name and email here.

Happy Holidays,
Peter


If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
PHD Ventures , 800 Corporate Pointe, Culver City CA, 90230






This email has been checked for viruses by Avast antivirus software.
www.avast.com


Tuesday, December 16, 2014

Fwd: G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry




-------- Original Message --------
Subject: G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry
Date: Tue, 16 Dec 2014 08:47:25 -0500 (EST)
From: Burrill Media LLC <news@b-c.com>
Reply-To: news@b-c.com
To: stevescott@techacq.com



 

G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry
Focus to shift from promise to execution in 2015

 

 

SAN FRANCISCO-DECEMBER 16, 2014-As the end of 2014 approaches, a year of unprecedented financial activity and dealmaking for the biotechnology industry, biotech visionary G. Steven Burrill issued his annual predictions for the life sciences in the new year.

Burrill, CEO of Burrill LLC and Burrill Media, says that though the biotechnology industry will likely see the capital markets slow somewhat in 2015, the new year is still expected to be one of solid performance by any traditional measure. At the same time, as the money that's been raised in 2014 gets deployed, the pace of innovation will increase, as will pressure from payers on pricing as the transformation of healthcare accelerates around the world. 


"The unprecedented IPO and M&A activity this year will make 2014 one for the record books and unlikely to ever be surpassed," says Burrill. "While we expect 2015 to be another strong year for the sector with robust financial markets and dealmaking, we do expect financing activity to slow as companies put to work all of the money that's been raised. But with important new drugs expected to be approved, attention will shift to away from the promise of companies to how well they execute."


PREDICTIONS

Capital Markets

IPOs
By the end of November 2014, 126 life sciences companies globally completed initial public offerings during the year raising nearly $10.4 billion (101 of those deals raised a combined $8.7 billion on U.S. exchanges). We expect another strong year for the IPO market in 2015, but it will be more like 2013 when a total of 49 companies completed IPOs on U.S. exchanges to raise $6.8 billion. One difference to look for in 2015 is greater activity on foreign exchanges as strengthening economies, rising markets, and companies in Europe and Asia raise money at home. In 2015 there will be 50 to 60 U.S. IPOs and 30 to 40 IPOs on overseas exchanges.

Fundraising
By the end of November, total global financings for the life sciences industry rose to $81.9 billion, just slightly ahead of the $79.5 billion raised during the same period the previous year. We expect 2015 to be a strong year for financings with growing activity in Asia and Europe, but down modestly from the level of activity seen this year.

Private Financings

Global venture capital investment in the life sciences reached $15.3 billion in the first 11 months of 2014, up from $11.5 billion during the same period the previous year. Venture investors are flush with new funds and are recycling capital thanks to the IPO and M&A activity of recent years. We expect 2015 to be a banner year for venture investment, but we'll also see a continued migration away from seed and early-stage biotechs that may be more than 10 years away from revenue. Increased capital will flow to new types of healthcare companies that leverage digital technologies to improve efficiency in the healthcare system, lead to new types of patient monitoring and early interventions, leverage data available to improve health, and transform access and delivery models.


Mergers and Acquisitions
Global M&A activity for the life sciences reached $340.8 billion in 2014, up from just $118.3 in 2013. Though changes in U.S. policy that remove incentives for using acquisitions to shift headquarters of U.S. companies to countries with lower tax rates will slow the so-called "inversions," we expect the brisk pace of M&A activity to continue as Big Pharma refreshes its pipelines through acquisitions. Look for 2015 to include some marquee companies in big dollar transactions. Companies will continue to buy, rather than build, to strengthen pipelines and grow revenues.


Partnering
The past year has been a good one for partnering with total potential deal values in the first 11 months rising to $47.9 billion from $35 billion during the same period a year ago. As with M&A activity, the trend toward externalization of R&D and the need for companies to look outside of their own walls for promising products will sustain activity. Despite some notable large upfront payments for highly desired experimental drugs, the bulk of payments will continue to be tied to commercial success.


Payers

Payers will continue to push back on the growing share of prescription drug spending that specialty pharmaceuticals represent. Payers will seek to create competition among drugmakers to lower prices, but drugs that provide unique benefit will continue to command high prices. The remarkable success of Gilead Sciences hepatitis C drug Sovaldi reshapes the conversation around pricing from questions of value to affordability. As a range of new regenerative medicine therapies move toward market and treatments give way to cures, there will be growing experimentation in payment models as questions over the durability of such therapies will be raised and there will be efforts to better link payment to performance. Moving from chronic care to cures will be the biotech industry's greatest contribution, and we'll see more of that in 2015.

Payers will also push back on a growing number of genomic based diagnostics that are aimed at stratifying patients, optimizing therapies, and improving outcomes. They will demand data that provide clear understanding of the utility and value of these tests. Right now, they are overwhelmed with trying to make sense of the value proposition of all the new generation diagnostics.


Healthcare

U.S. politics will continue to be characterized by partisanship as the Republican majorities in the House and Senate will look to dismantle unpopular aspects of the Patient Protection and Affordable Care Act, the Obama Administration's landmark healthcare reform legislation. With the power of the veto in President Obama's hands, serious threats to the law are more likely to come from the judiciary rather than the legislative branch. A decision to come in 2015 in King v. Burwell, a case that challenges the legality of tax credits to people who purchased health insurance in 34 states that did not establish their own health exchanges under the law, could affect care to 4.5 million people. In emerging markets, though, the healthcare systems of the future will begin to emerge as rapid change will be enabled by new technology. Rather than modernizing existing structures and technology to meet their needs, these systems are being built around new digital technologies that will provide decentralized models of delivery and capitalize on mobile and point-of-care diagnostics.

Biosimilars
The U.S. Food and Drug Administration has yet to resolve some of the questions about how it will handle biosimilars, but the industry isn't waiting. Biosimilars represent an area of important growth in global markets and drugmakers are starting to push through applications in the United States, even as the FDA has issues to address. We expect 2015 to be a year when biosimilars begin to gain traction in the market, especially globally.  Though the impact of biosimilars on biotechnology companies with branded products will be less dramatic than competition from generic drugs represented for Big Pharma companies, it will begin to exert pressure on companies as the biotech industry is approaching its own patent cliff. This will drive M&A and licensing activity as well for these companies. This pressure will accelerate in the next several years as the number of biosimilars grows and confidence in their safety and efficacy leads to broad acceptance.

Regulatory
Look for pressures on the U.S. Food and Drug Administration to ease the regulatory burden on drugmakers and find ways to accelerate the movement of drugs through the clinic and to the market. With Republican majorities in the House and Senate, momentum behind the 21st Century Cures Initiative, and the start of discussion on renewal of the Prescription Drug User Fee Act, the industry will be focused on forging a more industry-friendly regulatory agency and have the backing in Congress to do so.

Innovative Therapies
The arrival of cancer immunotherapies, gene therapy, and regenerative medicines represents a rapidly growing trend away from treating symptoms of disease to enlisting the body's own mechanism's to fight disease, repair itself, and in some cases provide cures.
 
Data
Drugmakers, payers, and providers will step up their investment in data analytics as they come to see that the key to competitive success will lie in their ability to gather, integrate, and analyze multiple, large datasets to drive decision making.  

Genomics
There will be a major shift away from next generation sequencing as a platform technology to the technology as a service as companies will make big investments to refine the genomics toolbox to use the technology as diagnostic tests.

Diagnostics
The increase in genomics will present challenges to assimilate the news discoveries and development tools. Look for more point-of-care diagnostics as technologies are used to speed and simplify tests.

National Institutes of Health
Budgets for research will continue to be under pressure from Congress. This will come as other governments around the world step-up efforts to fund R&D, increase their economic competitiveness, and encourage home grown entrepreneurship. We also expect continued pressure on the budget of the U.S. Food and Drug Administration

Global Markets
Drug and device companies will look to new markets in Asia where there will be robust growth and growing demand for innovative therapies as economic prosperity grows and spreads in these countries. With the historical U.S./Europe/Japan triumvirate getting all of the focus in prior generations, the new generation of companies will focus on China, non-China Asia, the Middle East, Africa, and individual countries with large populations and increased healthcare spending.

 

 

Summary
Overall, 2015 will be a banner year for the industry with an increased capital base, exciting new products, and expanding global needs.

 

About Burrill, LLC

Burrill. LLC is a life sciences/healthcare focused firm focused exclusively on company building, using its almost 50 years of experience capital, network capital, and expertise to help build the next generation of life science leaders. Burrill's global relationships with healthcare/life science leaders worldwide is without peer, providing Burrill portfolio companies and clients with sustainable competitive advantage.

Burrill Media is Burrill's information, intelligence, and insight business, publishing monthly, quarterly and annually developments in the life sciences/healthcare ecosystem. Burrill Media also hosts meetings and events for the life sciences/healthcare industry.


Contact:

Daniel Levine

Levine Media Group

(510) 280-5405

danny@levinemediagroup.com




 
 
 
 
 

ORDER TODAY
All-in-one

Reach nearly 25,000 life sciences thought leaders each week: 

To advertise in The Weekly Brief contact our business development team by clicking here

You are receiving this email because you have subscribed to the Weekly Brief or previously expressed an interest in The Burrill Report or other Burrill & Company publications or events.

 

Subscribe to The Burrill Report

 

Don't forget to join us on

 FacebookFacebook  or  TwitterTwitter 

 

   

ABOUT

SUBSCRIBE

  ADVERTISE

Copyright 2014 Burrill Media. All Rights Reserved.

 


Update Profile/Email Address
Instant removal with SafeUnsubcribe™ | Privacy Policy.
Burrill Media, LLC | 220 Halleck Street | Suite 120 | San Francisco | CA | 94129